Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists

Chris L. Bryson, Nicholas L. Smith, Lewis H. Kuller, Paulo H M Chaves, Teri A. Manolio, William Lewis, Edward J. Boyko, Curt D. Furberg, Bruce M. Psaty

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: To compare the risk of congestive heart failure (CHF) in elderly individuals treated with any peripheral alpha-1 antagonist for hypertension with any thiazide, test whether the risk persists in subjects without cardiovascular disease (CVD) at baseline, and examine CHF risk in normotensive men with prostatism treated with alpha antagonists. DESIGN: Prospective cohort study. SETTING: Four U.S. sites: Washington County, Maryland; Allegheny County, Pennsylvania; Sacramento County, California; and Forsyth County, North Carolina. PARTICIPANTS: A total of 5,888 community-dwelling subjects aged 65 and older. MEASUREMENTS: Adjudicated incident CHF. RESULTS: The 3,105 participants with treated hypertension were at risk for CHF; 22% of men and 8% of women took alpha antagonists during follow-up. The age-adjusted risk of CHF in those receiving monotherapy treated with alpha antagonists was 1.90 (95% confidence interval = 1.03-3.50) compared with thiazides. In subjects without CVD at baseline receiving monotherapy, women taking an alpha antagonist had a 3.6 times greater age-adjusted risk of CHF, whereas men had no difference in risk. Adjustment for systolic blood pressure attenuated statistical differences in risk. There were 930 men without hypertension at risk for CHF; 5% used alpha antagonists during follow-up, with no observed increase in CHF risk. CONCLUSION: Subjects receiving alpha antagonist monotherapy for hypertension had a two to three times greater risk of incident CHF, also seen in lower-risk subjects, but differences in blood pressure control partly explained this.

Original languageEnglish (US)
Pages (from-to)1648-1654
Number of pages7
JournalJournal of the American Geriatrics Society
Volume52
Issue number10
DOIs
StatePublished - Oct 2004

Fingerprint

Heart Failure
Population
Hypertension
Thiazides
Blood Pressure
Cardiovascular Diseases
Prostatism
Independent Living
Cohort Studies
Prospective Studies
Confidence Intervals

Keywords

  • Alpha-1 antagonist
  • Heart failure
  • Hypertension treatment
  • Thiazide

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Bryson, C. L., Smith, N. L., Kuller, L. H., Chaves, P. H. M., Manolio, T. A., Lewis, W., ... Psaty, B. M. (2004). Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists. Journal of the American Geriatrics Society, 52(10), 1648-1654. https://doi.org/10.1111/j.1532-5415.2004.52456.x

Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists. / Bryson, Chris L.; Smith, Nicholas L.; Kuller, Lewis H.; Chaves, Paulo H M; Manolio, Teri A.; Lewis, William; Boyko, Edward J.; Furberg, Curt D.; Psaty, Bruce M.

In: Journal of the American Geriatrics Society, Vol. 52, No. 10, 10.2004, p. 1648-1654.

Research output: Contribution to journalArticle

Bryson, CL, Smith, NL, Kuller, LH, Chaves, PHM, Manolio, TA, Lewis, W, Boyko, EJ, Furberg, CD & Psaty, BM 2004, 'Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists', Journal of the American Geriatrics Society, vol. 52, no. 10, pp. 1648-1654. https://doi.org/10.1111/j.1532-5415.2004.52456.x
Bryson, Chris L. ; Smith, Nicholas L. ; Kuller, Lewis H. ; Chaves, Paulo H M ; Manolio, Teri A. ; Lewis, William ; Boyko, Edward J. ; Furberg, Curt D. ; Psaty, Bruce M. / Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists. In: Journal of the American Geriatrics Society. 2004 ; Vol. 52, No. 10. pp. 1648-1654.
@article{4fff8ce349464c3cbaa53ff3d509b2fd,
title = "Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists",
abstract = "OBJECTIVES: To compare the risk of congestive heart failure (CHF) in elderly individuals treated with any peripheral alpha-1 antagonist for hypertension with any thiazide, test whether the risk persists in subjects without cardiovascular disease (CVD) at baseline, and examine CHF risk in normotensive men with prostatism treated with alpha antagonists. DESIGN: Prospective cohort study. SETTING: Four U.S. sites: Washington County, Maryland; Allegheny County, Pennsylvania; Sacramento County, California; and Forsyth County, North Carolina. PARTICIPANTS: A total of 5,888 community-dwelling subjects aged 65 and older. MEASUREMENTS: Adjudicated incident CHF. RESULTS: The 3,105 participants with treated hypertension were at risk for CHF; 22{\%} of men and 8{\%} of women took alpha antagonists during follow-up. The age-adjusted risk of CHF in those receiving monotherapy treated with alpha antagonists was 1.90 (95{\%} confidence interval = 1.03-3.50) compared with thiazides. In subjects without CVD at baseline receiving monotherapy, women taking an alpha antagonist had a 3.6 times greater age-adjusted risk of CHF, whereas men had no difference in risk. Adjustment for systolic blood pressure attenuated statistical differences in risk. There were 930 men without hypertension at risk for CHF; 5{\%} used alpha antagonists during follow-up, with no observed increase in CHF risk. CONCLUSION: Subjects receiving alpha antagonist monotherapy for hypertension had a two to three times greater risk of incident CHF, also seen in lower-risk subjects, but differences in blood pressure control partly explained this.",
keywords = "Alpha-1 antagonist, Heart failure, Hypertension treatment, Thiazide",
author = "Bryson, {Chris L.} and Smith, {Nicholas L.} and Kuller, {Lewis H.} and Chaves, {Paulo H M} and Manolio, {Teri A.} and William Lewis and Boyko, {Edward J.} and Furberg, {Curt D.} and Psaty, {Bruce M.}",
year = "2004",
month = "10",
doi = "10.1111/j.1532-5415.2004.52456.x",
language = "English (US)",
volume = "52",
pages = "1648--1654",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists

AU - Bryson, Chris L.

AU - Smith, Nicholas L.

AU - Kuller, Lewis H.

AU - Chaves, Paulo H M

AU - Manolio, Teri A.

AU - Lewis, William

AU - Boyko, Edward J.

AU - Furberg, Curt D.

AU - Psaty, Bruce M.

PY - 2004/10

Y1 - 2004/10

N2 - OBJECTIVES: To compare the risk of congestive heart failure (CHF) in elderly individuals treated with any peripheral alpha-1 antagonist for hypertension with any thiazide, test whether the risk persists in subjects without cardiovascular disease (CVD) at baseline, and examine CHF risk in normotensive men with prostatism treated with alpha antagonists. DESIGN: Prospective cohort study. SETTING: Four U.S. sites: Washington County, Maryland; Allegheny County, Pennsylvania; Sacramento County, California; and Forsyth County, North Carolina. PARTICIPANTS: A total of 5,888 community-dwelling subjects aged 65 and older. MEASUREMENTS: Adjudicated incident CHF. RESULTS: The 3,105 participants with treated hypertension were at risk for CHF; 22% of men and 8% of women took alpha antagonists during follow-up. The age-adjusted risk of CHF in those receiving monotherapy treated with alpha antagonists was 1.90 (95% confidence interval = 1.03-3.50) compared with thiazides. In subjects without CVD at baseline receiving monotherapy, women taking an alpha antagonist had a 3.6 times greater age-adjusted risk of CHF, whereas men had no difference in risk. Adjustment for systolic blood pressure attenuated statistical differences in risk. There were 930 men without hypertension at risk for CHF; 5% used alpha antagonists during follow-up, with no observed increase in CHF risk. CONCLUSION: Subjects receiving alpha antagonist monotherapy for hypertension had a two to three times greater risk of incident CHF, also seen in lower-risk subjects, but differences in blood pressure control partly explained this.

AB - OBJECTIVES: To compare the risk of congestive heart failure (CHF) in elderly individuals treated with any peripheral alpha-1 antagonist for hypertension with any thiazide, test whether the risk persists in subjects without cardiovascular disease (CVD) at baseline, and examine CHF risk in normotensive men with prostatism treated with alpha antagonists. DESIGN: Prospective cohort study. SETTING: Four U.S. sites: Washington County, Maryland; Allegheny County, Pennsylvania; Sacramento County, California; and Forsyth County, North Carolina. PARTICIPANTS: A total of 5,888 community-dwelling subjects aged 65 and older. MEASUREMENTS: Adjudicated incident CHF. RESULTS: The 3,105 participants with treated hypertension were at risk for CHF; 22% of men and 8% of women took alpha antagonists during follow-up. The age-adjusted risk of CHF in those receiving monotherapy treated with alpha antagonists was 1.90 (95% confidence interval = 1.03-3.50) compared with thiazides. In subjects without CVD at baseline receiving monotherapy, women taking an alpha antagonist had a 3.6 times greater age-adjusted risk of CHF, whereas men had no difference in risk. Adjustment for systolic blood pressure attenuated statistical differences in risk. There were 930 men without hypertension at risk for CHF; 5% used alpha antagonists during follow-up, with no observed increase in CHF risk. CONCLUSION: Subjects receiving alpha antagonist monotherapy for hypertension had a two to three times greater risk of incident CHF, also seen in lower-risk subjects, but differences in blood pressure control partly explained this.

KW - Alpha-1 antagonist

KW - Heart failure

KW - Hypertension treatment

KW - Thiazide

UR - http://www.scopus.com/inward/record.url?scp=6944231103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6944231103&partnerID=8YFLogxK

U2 - 10.1111/j.1532-5415.2004.52456.x

DO - 10.1111/j.1532-5415.2004.52456.x

M3 - Article

VL - 52

SP - 1648

EP - 1654

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 10

ER -